Replies to post #227050 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

That's the $64,000 question: will a combo trial include a large upfront payment from the partner? If yes, that would be good enough news that might offset a further delay in reporting TLD. Hard to say until that bridge is crossed.

I don't think the start of another trial would be big news. They have been talking for a long time about two trials that haven't started yet. NWBO does not have the money to start another trial AND finish the phase 3 trial. So, if someone like BMY is so confident that they agree to pay for the whole trial and announce the start of it, I guess that would be decent news. The only thing, IMO, that gets the stock over $1, brings in warrant money and gets the other trials started is topline release, period.